Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Feb 2024 – 20 Aug 2026, limited by Axis BSE Sensex Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis BSE Sensex Index Fund | Nifty 50 |
|---|---|---|
| 29 Feb 2024 | ₹100.00 | ₹100.00 |
| 14 May 2024 | ₹101.00 | ₹101.07 |
| 29 Jul 2024 | ₹112.83 | ₹112.98 |
| 12 Oct 2024 | ₹113.08 | ₹113.56 |
| 26 Dec 2024 | ₹109.15 | ₹108.04 |
| 11 Mar 2025 | ₹103.17 | ₹102.34 |
| 26 May 2025 | ₹114.48 | ₹113.73 |
| 09 Aug 2025 | ₹111.97 | ₹110.83 |
| 23 Oct 2025 | ₹118.75 | ₹117.78 |
| 06 Jan 2026 | ₹119.62 | ₹119.09 |
| 23 Mar 2026 | ₹102.43 | ₹102.41 |
| 06 Jun 2026 | ₹104.82 | ₹106.30 |
| 20 Aug 2026 | ₹110.04 | ₹110.23 |
| Metric | Axis · Direct · IDCW NAV ₹10.92 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| -4.24% | +5.06% | |
| — | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +3.95% | +7.54% | |
| -0.36% | — | |
| — | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 13.55% | 13.54% | |
| -0.79 | 0.16 | |
| -1.10 | 0.22 | |
| -15.95% | -15.77% | |
| Nifty 50 | — | |
| -0.10% | +0.53% | |
| 0.99 | 1.00 | |
| 100.9% | 102.2% | |
| 101.5% | 98.0% | |
| 0.24% | 0.34% | |
| ₹54.80Cr | ₹191.88Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹500 | — | |
| — | 38% | |
| Karthik Kumar | — | |
| 29 Feb 2024 | — | |
| 30 | — | |
| 64.3% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.